Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diabetic Foot UlcerInfection
Interventions
DRUG

Plurogel PN

Trial Locations (15)

19103

Paddington Testing Company, Inc, Philadelphia

23464

Coastal Podiatry Group, Virginia Beach

33016

Sweet Hope Research Specialty, Inc., Miami Lakes

33135

Advance Medical Research Center, Miami

33144

Miami Center for Clinical Research, LLC, Miami

Unlimited Medical Research, LLC, Miami

33165

Phoenix Medical Research, LLC, Miami

33186

Med Research of Florida, LCC, Miami

42303

Research Integrity, Owensboro

60016

Weil Foot & Ankle Institute, Des Plaines

76015

AllCare Foot & Ankle, PA, Arlington

85032

Ledesma Foot and Ankle, Phoenix

90010

Foot & Ankle Clinic, Los Angeles

94609

Samuel Merritt University, Oakland

06514

ASAP Urgent-Care, Hamden

All Listed Sponsors
collaborator

Arkios BioDevelopment International

INDUSTRY

lead

PluroGen Therapeutics, Inc

INDUSTRY